Investigating neurocognitive features of hepatitis C virus infection in drug users: Potential challenges and lessons learned from the HIV literature

Clinical Infectious Diseases

Volumn 41, Issue 1 SUPPL., 2005, Pages

  Gonzalez, Raul ^a   Jacobus, Joanna ^a   Martin, Eileen M ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; DIAMORPHINE; METHAMPHETAMINE; OPIATE;

BRAIN FUNCTION; CLINICAL FEATURE; COGNITION; COGNITIVE DEFECT; DEPRESSION; DISEASE ASSOCIATION; DRUG USE; FATIGUE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEARNING; LEARNING DISORDER; LIVER DISEASE; MEDICAL LITERATURE; PRIORITY JOURNAL; REVIEW; UNITED STATES;

ADULT; BRAIN; CHICAGO; COGNITION DISORDERS; HEPATITIS C; HIV INFECTIONS; HUMANS; MIDDLE AGED; RESEARCH; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 20844463084     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/429495     Document Type: Review

References (17)

1. Pohl A, Behling C, Oliver D, Kilani M, Monson P, Hassanein T. Recommendations from the National Institutes of Health consensus development conference statement: management of hepatitis C, 2002. Hepatology 2002; 36:1039.
2. Basso MR, Bornstein RA. Neurobehavioural consequences of substance abuse and HIV infection. J Psychopharmacol 2000; 14:228-37.
3. Forton DM, Thomas HC, Murphy CA, et al. Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology 2002; 35:433-9.
4. Forton DM, Allsop JM, Main J, Foster GR, Thomas HC, Taylor-Robinson SD. Evidence for a cerebral effect of the hepatitis C virus. Lancet 2001; 358:38-9.
5. Taylor MJ, Letendre SL, Schweinsburg BC, et al. Hepatitis C virus infection is associated with reduced white matter N-acetylaspartate in abstinent methamphetamine users. J Int Neuropsychol Soc 2004; 10: 110-3.
6. Kramer L, Bauer E, Funk G, et al. Subclinical impairment of brain function in chronic hepatitis C infection. J Hepatol 2002; 37:349-54.
7. Vargas H, Laskus T, Radkowski M, et al. Detection of hepatitis C virus sequences in brain tissue obtained in recurrent hepatitis C after liver transplantation. Liver Transpl 2002; 8:1014-9.
8. Maggi F, Giorgi M, Fornai C, et al. Detection and quasispecies analysis of hepatitis C virus in the cerebrospinal fluid of infected patients. J Neurovirol 1999; 5:319-23.
9. Forton DM, Taylor-Robinson SD, Thomas HC. Cerebral dysfunction in chronic hepatitis C infection. J Viral Hepat 2003; 10:81-6.
10. Hilsabeck RC, Hassanein TI, Carlson MD, Ziegler EA, Perry W. Cognitive functioning and psychiatric symptomatology in patients with chronic hepatitis. J Int Neuropsychol Soc 2003; 9:847-54.
11. Ryan EL, Morgello S, Isaacs K, Naseer M, Gerits P. Neuropsychiatric impact of hepatitis C on advanced HIV. Neurology 2004; 62:957-62.
12. Von Giesen HJ, Heintges T, Abbasi-Boroudjeni N, et al. Psychomotor slowing in hepatitis C and HIV infection. J Acquir Immune Defic Syndr 2004; 35:131-7.
13. Navia BA, Cho ES, Petito CK, Price RW. The AIDS dementia complex. II. Neuropathology. Ann Neurol 1986; 19:525-35.
14. Hinkin CH, Hardy DJ, Mason KI, et al. Verbal and spatial working memory performance among HIV-infected adults. J Int Neuropsychol Soc 2002; 8:532-8.
15. Reger M, Welsh R, Razani J, Martin DJ, Boone KB. A meta-analysis of the neuropsychological sequelae of HIV infection. J Int Neuropsychol Soc 2002; 8:410-24.
16. Forton DM, Thomas HC, Taylor-Robinson SD. Quality of life and cognitive function in chronic hepatitis C-what to measure? J Hepatol 2003; 39:272-4.
17. Martin EM, Novak RM, Fendrich M, et al. Stroop performance in drug users classified by HIV and hepatitis C virus serostatus. J Int Neuropsychol Soc 2004; 10:298-300.